Metraipolis › archive › dc_8b82cd801475
Patient-derived organoids (PDOs): a novel preclinical platform to overcome challenges in cancer immunotherapy — Europe PMC PMID:41788310
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41788310
- DOI
- 10.3389/fcell.2026.1757516
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T16:32:36.187Z
- SHA-256 of the archived text
73f12a433e0cd0b8c731227c8454924e509622c2978365d1a112d3e2065bce44- Stable URL of this page
https://metraipolis.com/documento/dc_8b82cd801475
How to cite
Patient-derived organoids (PDOs): a novel preclinical platform to overcome challenges in cancer immunotherapy — Europe PMC PMID:41788310 — Europe PMC (en), https://europepmc.org/article/MED/41788310 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8b82cd801475 (Metraipolis archive dc_8b82cd801475, sha256 73f12a433e0cd0b8c731227c8454924e509622c2978365d1a112d3e2065bce44)
BibTeX
@misc{dc8b82cd801475,
title = {Patient-derived organoids (PDOs): a novel preclinical platform to overcome challenges in cancer immunotherapy — Europe PMC PMID:41788310},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41788310},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8b82cd801475; sha256 73f12a433e0cd0b8c731227c8454924e509622c2978365d1a112d3e2065bce44},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41788310. Agents can read the archived copy with the MCP tool read_document.